Sentences with phrase «specialty pharma companies»

Among them were a few specialty pharma companies as well as some biotechs.

The environment for deals among specialty pharma companies like Jazz has heated up since the beginning of the year.

That's leaving entire areas open for the taking and Valeant — a specialty pharma company that focuses on dermatology, ophthalmology and over-the-counter medications — which already has a strong foothold in emerging markets is poised to fill that void.

That deal cemented Actavis's rebirth as a branded and specialty pharma company — or as CEO Brent Saunders said, a pioneer «in a new industry model: Growth Pharma.»

Not exact matches

But the initiative comes with another huge financial prize for firms that successfully win FDA approval for these niche therapies: a priority review voucher that can be used to slash the regulatory period for a different experimental specialty treatment being developed by a drug maker or, more often, sold for potentially hundreds of millions of dollars to another pharma company.

We cover biopharma companies end - to - end — whether they're small, specialty drugmakers, generics companies or the biggest of Big Pharma — highlighting the accomplishments and acknowledging the defeats that all of them experience in the complicated, competitive pharmaceuticals industry.

He also is a director and non-executive Chairman of Mayne Pharma Group Limited, an Australian specialty pharmaceutical company (which recently purchased Metrics, Inc., a pharmaceutical company in North Carolina), and a former member of the Prime Minister's Community Business Partnership.

The company is moving its auto, building, water, pharma and food, microbial control and performance polymers from the materials science division to the specialty products group.

Massimo also serves as Executive Chairman of Bioakos Pharma, a specialty pharmaceutical company based in Florence, Italy, and focused in the areas of dermatology, gynecology and pediatrics.

Horizon Pharma Plc is a specialty biopharmaceutical company, which engages in the business of identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs.

So with the understanding that I sure as hell know what pervasive influence peddling can do to the process of peer review — because the pharma companies do actively recruit their «key opinion leaders» on the basis of things like editorial clout and that prominence within their specialty which gives them to hold responsibilities in peer review for «high impact» medical journals — you might appreciate why, when I got to read those e-mails in the FOI2009.zip archive last November, my immediate desire was for something brutally Sicilian to happen immediately and with spatter marks on the surrounding walls to the C.R.U. correspondents who had been concerting to infest and pervert the peer review process throughout the physical sciences wherever anything critical of the AGW hypothesis might be brought into publication.

The investment firm plans to invest $ 10 million to $ 30 million in specialty pharma, and medtech companies.

Galenica Group recently announced that it has entered into a definitive agreement to acquire the US company Relypsa, Inc., (NASDAQ: RLYP), further strengthening its Business unit Vifor Pharma by gaining full global rights to the potassium binder Veltassa ® (patiromer) for oral suspension and enhancing its growing position as a global specialty pharmaceutical company.